Looks like we might be attracting some interest from the scientific community....let's see if I can paste this:
-
Epigenetics Experts Retweeted Resverlogix Corp.
A BET inhibitor specific for BRD2, in PhaseIII clinical trial for diabetics w/ high-risk cardiovascular disease. -NK
Epigenetics Experts added,
Resverlogix Corp. @Resverlogix_RVX
-
Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET protein BRD4. Thank you @SartorGreg @EpiExperts